Showing 1 - 12 results of 12 for search 'Yu V Muravyev', query time: 0.02s Refine Results
  1. 1
    WHY IS THE STUDY OF THE COMPLEX SAFETY OF CELECOXIB FOR ARTHRITIS, WHICH IS CALLED PRECISION, LAST BUT NOT LEAST?

    WHY IS THE STUDY OF THE COMPLEX SAFETY OF CELECOXIB FOR ARTHRITIS, WHICH IS CALLED PRECISION, LAST BUT NOT LEAST? by Yu. V. Muravyev

    Published 2017-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    DIAGNOSTIC AND CLASSIFICATION CRITERIA IN RHEUMATOLOGY: WHEN SHOULD THE CRITERIA BE USED AND HOW DO THEY DIFFER?

    DIAGNOSTIC AND CLASSIFICATION CRITERIA IN RHEUMATOLOGY: WHEN SHOULD THE CRITERIA BE USED AND HOW DO THEY DIFFER? by Yu. V. Muravyev

    Published 2017-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The evolution of discussion ideas on drug-induced disease

    The evolution of discussion ideas on drug-induced disease by Yu. V. Muravyev, L. A. Muravyeva

    Published 2016-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    ChTO DELAT'', ESLI V PERIOD LEChENIYa INGIBITORAMI FAKTORA NEKROZA OPUKhOLI α VOZNIK PSORIAZ?

    ChTO DELAT'', ESLI V PERIOD LEChENIYa INGIBITORAMI FAKTORA NEKROZA OPUKhOLI α VOZNIK PSORIAZ? by Yu. V. Muravyev, I. A. Doroshkevich

    Published 2011-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis

    The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis by Yu. V. Muravyev, L. A. Muravyeva

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Bases for the study of the safety of medicines. The spectrum of rare and unexpected ad-verse reactions of bisphosphonates

    Bases for the study of the safety of medicines. The spectrum of rare and unexpected ad-verse reactions of bisphosphonates by I S Dydykina, P S Dydykina, Yu V Muravyev

    Published 2011-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease

    The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease by Yu. V. Muravyev, V. V. Lebedeva, S. I. Glukhova

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG TABLETS PER WEEK FOR RHEUMATOID ARTHRITIS

    TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG T... by Yu. V. Muravyev, V. I. Mazurov, E. L. Nasonov

    Published 2016-07-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    The reaction of the skin and its appendages in rheumatoid arthritis patients using subcutaneous methotrexate: A description of three cases

    The reaction of the skin and its appendages in rheumatoid arthritis patients using subcutaneous methotrexate: A description of three cases by Yu. V. Muravyev, G. I. Gridneva, S. G. Radenska-Lopovok, N. I. Kharitonova

    Published 2016-10-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis

    The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing sp... by Yu. V. Muravyev, V. V. Lebedeva, A. S. Starkova, D. G. Rumyantseva, M. M. Urumova, Sh. Erdes

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    EFFICACY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS

    EFFICACY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS by M. S. Naumtseva, B. S. Belov, G. M. Tarasova, D. E. Karateev, E. L. Luchikhina, Yu. V. Muravyev, E. N. Aleksandrova, A. A. Novikov

    Published 2015-05-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS

    THE FIRST RUSSIAN STRATEGIC STUDY OF PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS (REMARCA TRIAL): RESULTS OF 12-MONTH TREATMENT IN 130 PATIENTS by D. E. Karateev, E. L. Luchikhina, N. V. Demidova, G. S. Gridneva, M. A. Kanonirova, Yu. V. Muravyev, G. V. Lukina, Yu. A. Olyunin, K. A. Kasumova, E. N. Aleksandrova, A. A. Novikov, A. A. Avdeeva, T. V. Popkova, D. S. Novikova, A. V. Smirnov, A. V. Volkov, E. L. Nasonov

    Published 2014-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: